Jeff Legos

Jeff Legos is a distinguished professional with a solid educational background and extensive experience in the pharmaceutical industry.

He holds a degree from Villanova University School of Business and has also studied at Temple University School of Medicine, showcasing a diverse academic foundation.

Currently, Jeff Legos serves as the Executive Vice President and Global Head of Oncology & Hematology Development at Novartis, underlining his prominent role in leading cancer research and drug development globally.

Prior to his current position, he held multiple high-ranking roles at Novartis, including Senior Vice President in various oncology-related departments, demonstrating his expertise and growth within the organization.

Before joining Novartis, Jeff Legos gained valuable experience at GSK Oncology R&D, where he served in several key positions such as Vice President, Senior Director, and Head of Business Planning Strategy, Portfolio Management, & Executive Operations.

His professional journey reflects a strategic and impactful career in the pharmaceutical sector, with a focus on oncology research and development.

Jeff Legos's leadership and contributions have significantly influenced the advancement of treatments in oncology and hematology, making him a respected figure in the industry.